Achieving clinical remission for your female patients of childbearing age (aged 18–45)
Professor Nico Wulffraat is a paediatric rheumatologist and immunologist and full professor within the Department of Paediatrics, Subunit Paediatric Immunology and Rheumatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, The Netherlands.
Professor Wulffraat completed his medical degree at the Free University, Amsterdam, The Netherlands, and was later awarded a PhD from the same institution. His research interests focus on paediatric rheumatology, and he set up the European project Pharmachild and the European project SHARE on clinical guidelines in paediatric rheumatology. Additionally, Professor Wulffraat is the coordinator of the European Reference Network (ERN) RITA.
Professor Wulffraat is a member of committees such as the Gezondheidsraad Advies CVS (chronic fatigue syndrome) and the Evaluatie Beoordeling NFU Expertisecentra. He has also contributed to over 330 peer-reviewed papers.
Join Dr Lykke Midtbøll Ørnbjerg as she explores the value of registry data for informing clinical practice in axSpA.
Watch Dr Floris van Gaalen explore whether early diagnosis of axSpA is possible, drawing on findings from the SPACE cohort.1
Achieving clinical remission for your female patients of childbearing age (aged 18–45)
Accompany Dr William Tillett and Dr Fabian Proft as they explore the approaches and challenges of managing D2T patients with PsA.
Achieving MDA or DAPSA treatment targets improves quality of life for patients with PsA.1–4 Explore the characteristics of patients who report treatment success...
ASDAS and BASDAI are commonly used in clinical practice.1,2 However, discover recent studies demonstrating that a high proportion of real-world patients do not...